Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/49913
Chapter/Book title: Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation.
Authors: Jin D.;Loh K.L.;Shamekhi T.;Ting Y.T.;Lim Kam Sian T.C.C.;Roest J.;Ooi J.D.;Vivian J.P.;Faridi P.
Monash Health Department(s): Monash University - School of Clinical Sciences at Monash Health
Centre for Inflammatory Diseases at Monash Health
Institution: (Jin, Shamekhi, Lim Kam Sian, Faridi) Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia
(Loh, Ting, Ooi) Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia
(Lim Kam Sian, Faridi) Monash Proteomics & Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
(Roest, Vivian) St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia
(Vivian) Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
Publication year: 3-Jul-2023
Copyright year: 2023
Publisher: Humana Press Inc.
Place of publication: United States
Publication information: Methods in Molecular Biology. 2691 (pp 351-369), 2023. Date of Publication: 2023.
Book title: Methods in Molecular Biology
Abstract: Epitope-specific immunotherapies have enabled the targeted treatment of a variety of diseases, ranging from cancer, infection, and autoimmune disorders. For CD8+ T cell-based therapies, the precise identification of immunogenic peptides presented by human leukocyte antigen (HLA) class I is essential which can be achieved by immunopeptidomics. Here, using lentivirus-mediated transduction and cell sorting approaches, we present a method to engineer a cell line that does not express its native HLA but instead expresses an HLA of interest (in this instance HLA-A*02:01). This technique can be used to elucidate the immunopeptidome of cell lines expressing different HLAs.Copyright © 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1007/978-1-0716-3331-1_25
PubMed URL: 37355557 [https://www.ncbi.nlm.nih.gov/pubmed/?term=37355557]
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/49913
Type: Chapter
Subjects: gene editing
gene expression
immunotherapy
Lentivirus
malignant neoplasm
protein expression
leukocyte antigen
Appears in Collections:Books and Book Chapters

Show full item record

Page view(s)

38
checked on May 19, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.